DIAGNOSTIC KITS, GENETIC MARKERS, AND METHODS FOR SCD OR SCA THERAPY SELECTION

摘要

Variations in certain genomic sequences useful as genetic markers of Sudden Cardiac Death ("SCD"), or Sudden Cardiac Arrest ("SCA") risk, are described. Novel diagnostic kits and methods employing these genetic markers are used in assessing the risk of SCD, or SCA. Methods of distinguishing patients having an increased susceptibility to SCD, or SCA, through use of these markers, alone or in combination with other markers, are also provided. Further, methods for assessing the need for an Implantable Cardio Defibrillator ("ICD") in a patient with computer programmable processors and genetic databases are described.